Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 4Sarcoma 3Lymphoid 1Head & Neck 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Head and Neck Neoplasms 6Squamous Cell Carcinoma of Head and Neck 4Triple Negative Breast Neoplasms 3Salivary Gland Neoplasms 3Colorectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Stomach Neoplasms 2Small Cell Lung Carcinoma 2Pancreatic Neoplasms 2Colonic Neoplasms 2Breast Neoplasms 2Wilms Tumor 1Uterine Cervical Neoplasms 1Tongue Neoplasms 1Thyroid Neoplasms 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Neoplasms 1Nasopharyngeal Neoplasms 1Melanoma 1Medulloblastoma 1Lymphoma, Large B-Cell, Diffuse 1Gastrointestinal Stromal Tumors 1Gallbladder Neoplasms 1

Interventions

Oxaliplatin 2Temozolomide 1Tamoxifen 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Irinotecan 1Filgrastim 1Doxorubicin 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Optic Nerve Glioma × Irinotecan × Head & Neck × Clear all
NCT00101270 2013-06-05

Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas

National Cancer Institute (NCI)

Phase 1 Completed
24 enrolled
CNSDermatologicGastrointestinalGenitourinaryHead & NeckLymphoidSarcoma

Familial ependymoma, Astrocytoma, Burkitt Lymphoma, Colonic Neoplasms, Medulloblastoma, Melanoma, Nasopharyngeal Neoplasms, Wilms Tumor, Neuroblastoma, Recurrence, Osteosarcoma, Lymphoma, Large B-Cell, Diffuse, Neuroectodermal Tumors, Primitive, Peripheral, Optic Nerve Glioma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡